2017 Pilot and Feasibility Projects

SECIM is committed to offering pilot and feasibility funding for projects that support the advancement of metabolomics. See below to view past awardees, their funded projects and their research.

For additional pilot awards and funding opportunities, please visit the UF CTSI.

elisabeth barton

“Defining metabolic shifts in mouse muscles lacking IGF-I production”

PI:  Elizabeth Barton, University of Florida

kathryn blake

“Using Metabolomics and Lipidomics Analysis to Explore Metabolites and Pathways Associated Increased Airway Hyperresponsiveness in Patients with Asthma who are Identified by Race (African American) and Genotype (ADRB2 Arg16/Arg)”

PI:  Kathryn Blake, Nemours Children’s Hospital

mariola edelmann

“Profiling of extracellular and exosome-contained metabolites in Salmonella infection”

PI: Mariola Edelmann, University of Florida

kelly ethun

“Milk Metabolomics and Infant Neurodevelopment in the Rhesus Macaque Model”

PI: Kelly Ethun, Emory University

michelle gumz

“Urinary Metabolite Profile of Non-Dipping Hypertension”

PI: Michelle Gumz, University of Florida

Jennifer Kwong

“Integrated Metabolomics in Aggressive Bladder Cancer”

PI: Jennifer Kwong, Emory University

george kyriazis

“Skeletal Muscle Sweet Taste Receptors and Nutrient Utilization”

PI: George Kyriazis, Sanford Burnham Prebys Medical Discovery Institute

wellington rody

“Metabolomic profiling of gingival crevicular fluid (GCF) in the presence of dentin resorption”

PI: Wellington Rody Jr, University of Florida

joseph ryan

“Using comparative metabolomics to understand growth and salt tolerance in mangroves”

PI: Joseph Ryan, University of Florida

erwin meir

“Define mechanism of action and metabolic vulnerabilities induced by novel anti-cancer agent 64B”

PI: Erwin Van Meir, Emory University

Rui Xiao

“Metabolic profiling of a ketogenic diet-triggered anti-aging effects in C. elegans”

PI: Rui Xiao, University of Florida

Yi Xu

“Determine metabolomics signatures important for the ability of Streptococus gallolyticus to promote colon cancer cell proliferation”

PI: Yi Xu, Texas A&M University

SECIM services

SECIM provides state-of-the-art metabolomics services to users in all areas of biomedical and biological sciences. For more information, including pricing, or to schedule a consultation, please contact us.

For additional pilot funding information provided by SECIM’s national NIH metabolomics consortium partners, please visit their websites: